Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice

A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet

(2011) Mitsunari Ogasawara et al.   LIVER INTERNATIONAL

Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease

(2009) Yoichiro Kitajima et al.   JOURNAL OF GASTROENTEROLOGY

Preventive Effects of Bofutsushosan on Obesity and Various Metabolic Disorders

(2008) Tsutomu Shimada et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The Kampo Medicines Orengedokuto, Bofutsushosan and Boiogito Have Different Activities to Regulate Gene Expressions in Differentiated Rat White Adipocytes: Comprehensive Analysis of Genetic Profiles

(2008) Jun-ichi Yamakawa et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Molecular Mechanism of Moderate Insulin Resistance in Adiponectin-Knockout Mice

(2008) Wataru YANO et al.   ENDOCRINE JOURNAL

Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

(2008) Kengo Tomita et al.   HEPATOLOGY

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

(2008) Catherine Postic et al.   JOURNAL OF CLINICAL INVESTIGATION

Adipocytokines and liver disease

(2008) Yoshihiro Kamada et al.   JOURNAL OF GASTROENTEROLOGY